siRNAs targeting cyclin E induce apoptosis and tumor regression, whereas VEGF- or integrin-targeted siRNAs delivered via nanoparticle systems delay tumor progression, reduce macrophage infiltration, and improve survival [31,32,33]. Here, VEGFA is linked to neoplasm.